Error: Could not add to watchlist. X
+ Watchlist

Alcobra Ltd

ADHD:US
NASDAQ GM
3.86
USD
0.33
7.88%
As of 8:10 PM EDT 5/4/2016
Open
4.16
Day Range
3.85 - 4.19
Volume
101,317
Previous Close
4.19
52Wk Range
3.15 - 9.50
1 Yr Return
-31.07%
Open
4.16
Day Range
3.85 - 4.19
Volume
101,317
Previous Close
4.19
52Wk Range
3.15 - 9.50
1 Yr Return
-31.07%
YTD Return
-38.54%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.90
Market Cap (m USD)
106.385
Shares Outstanding (m)
27.561
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Alcobra Ltd. operates as a biopharmaceutical company. The Company develops a patented, non-stimulant pharmaceutical drug designed to treat Attention Deficit Hyperactivity Disorder and other cognitive disorders.
Address
35 Ehad Ha-Am Street
4th Floor
Tel Aviv, 65202
Israel
Phone
9-72-72-220-4661
Show More